The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis

The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis

Objective. The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (AN...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fei Huang, Yueqiang Li, Ranran Xu, Anying Cheng, Yongman Lv, Qingquan Liu
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2020/7850179
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Value of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Term Neonates with Infection or Sepsis: A Prospective Study
by: Tania Siahanidou, et al.
Published: (2014-01-01)

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
by: Wenwen Zhang, et al.
Published: (2024-12-01)

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
by: Ranadheer R. Dande, et al.
Published: (2017-01-01)

Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes
by: Fatima Ali Essa Al-Sudani, et al.
Published: (2024-01-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age
by: Clara Preto, et al.
Published: (2017-01-01)

Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis
by: Sandra Lilliebladh, et al.
Published: (2018-01-01)

P-ANCA Systemic Vasculitis Induced by Brucellosis in an Elderly Male Patient
by: Mohammed Cheikh, et al.
Published: (2021-01-01)

What Has Changed in the New Guidelines in the Treatment of ANCA-Associated Vasculitis?
by: Kadir Gökhan Atılgan
Published: (2025-01-01)

Functional Stability of Plasminogen Activator Inhibitor-1
by: Songul Yasar Yildiz, et al.
Published: (2014-01-01)

ANCA Associated Vasculitis and Renal Failure Related to Propylthiouracil and Hyperthyroidism Induced Cholestasis in the Same Case
by: Mehmet Tuncay, et al.
Published: (2014-01-01)

A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis
by: Neveen Awad, et al.
Published: (2016-01-01)

A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the Literature
by: Richard A. Lau, et al.
Published: (2017-01-01)

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
by: Bram M. Voorzaat, et al.
Published: (2017-01-01)

USP25 attenuates anti-GBM nephritis in mice by negative feedback regulation of Th17 cell differentiation
by: Ranran Xu, et al.
Published: (2024-12-01)

Pericardial Tamponade: An Uncommon Clinical Presentation in cANCA Related Vasculitis and Glomerulonephritis in Association with Very High Titres of ANA
by: Amaresh Vanga, et al.
Published: (2019-01-01)

The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier
by: Jun Muratsu, et al.
Published: (2012-01-01)

Diagnosing and Treating ANCA-Associated Vasculitis within the COVID-19 Era: A Challenging Case Report
by: Erjola Likaj, et al.
Published: (2025-01-01)

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
by: Archit Bhatt, et al.
Published: (2013-01-01)

Plasminogen Activator Inhibitor-1 Regulates LPS Induced Inflammation in Rat Macrophages through Autophagy Activation
by: Zhong-Hui Wang, et al.
Published: (2014-01-01)

Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
by: I. V. Kaplieva, et al.
Published: (2024-09-01)

PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature
by: Amanda Ramos, et al.
Published: (2020-01-01)

ANCA-Negative Vasculitis in Eosinophilic Granulomatosis with Polyangiitis Complicated with Membranous Nephropathy: A Case Report and Brief Literature Review
by: Eri Kasama, et al.
Published: (2022-01-01)

The Pathogenic Role of Expanded CD8⁺CD28<sup>null</sup> Angiogenic T Cells in ANCA-Associated Vasculitis
by: Haomiao Shen, et al.
Published: (2024-12-01)

Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
by: E. M. Frantsiyants, et al.
Published: (2022-03-01)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
by: Sándor Somodi, et al.
Published: (2018-01-01)

Use of the Recombinant Tissue Plasminogen Activator in the Management of Complex Infected Intraperitoneal Fluid Collection
by: Aibek E. Mirrakhimov, et al.
Published: (2019-01-01)

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
by: Benjamin Chaucer, et al.
Published: (2018-01-01)

Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
by: Kathleen Minor, et al.
Published: (2020-01-01)

Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study
by: Anna Salmela, et al.
Published: (2018-01-01)

Binding and cleavage of pro-urokinase by a tegument extract of Fasciola hepatica newly excysted juveniles activate the host fibrinolytic system
by: Judit Serrat, et al.
Published: (2025-01-01)

Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease
by: Qingquan Chen, et al.
Published: (2021-01-01)

Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery
by: Simon S. M. Fung, et al.
Published: (2015-01-01)

Evaluation of Retinal Pigment Epithelial Cell Cytotoxicity of Recombinant Tissue Plasminogen Activator Using Human-Induced Pluripotent Stem Cells
by: Hiroyuki Kamao, et al.
Published: (2019-01-01)

Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
by: Agnieszka Nowosielska, et al.
Published: (2024-03-01)

Biological significance of soluble IL-2 receptor
by: Calogero Caruso, et al.
Published: (1993-01-01)

Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review
by: Sohail Farshad, et al.
Published: (2019-01-01)

Incidence of Apoptosis in the Lymphoid Organs of Normalor Malaria Infected Mice is Decreased in CD18 andUrokinase - Receptor (UPAR, CD87) Deficient Mice
by: Pierre Francois Piguet, et al.
Published: (2001-01-01)

Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
by: Katarina Lalić, et al.
Published: (2015-01-01)

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
by: Irene Lambrinoudaki, et al.
Published: (2013-01-01)